Cryo-Cell International Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingNov 2024Nov 2023Nov 2022Nov 2021Nov 2020
Valuation Ratios
P/E Ratio173.8413.4350.6815.61
P/S Ratio2.191.411.233.661.82
P/B Ratio-5.29-4.02-24.4225.24-21.23
Price/FCF19.3821.3117.336.76
Price/OCF11.634.974.3413.326.68
Enterprise Value Ratios
EV/Revenue2.491.771.443.511.78
EV/EBITDA17.7348.197.3423.749.11
EV/EBIT20.979.8031.369.70
EV/FCF22.0426.7016.666.63
Profitability & Returns
Return on Equity (ROE)2.08%2.74%
Return on Assets (ROA)0.04%0.00%0.04%0.04%0.08%
Return on Invested Capital (ROIC)-0.07%1.06%
Return on Capital Employed (ROCE)0.09%-0.01%0.10%0.08%0.19%
Leverage & Solvency Ratios
Debt/Equity-0.98-0.99-7.620.67-2.34
Debt/EBITDA2.627.011.840.610.97
Debt/FCF3.595.240.460.75
Liquidity Ratios
Current Ratio0.580.450.490.751.13
Quick Ratio0.500.370.400.651.02
Efficiency Ratios
Asset Turnover0.510.500.480.540.70
Inventory Turnover11.1414.979.9210.9910.88
Yield & Distribution Ratios
Earnings Yield0.01%-0.21%0.07%0.02%0.06%
FCF Yield0.05%0.05%-0.10%0.06%0.15%
Dividend Yield0.03%
Payout Ratio5.03%
Buyback Yield0.02%0.02%-0.01%-0.03%0.03%
Total Return0.05%0.02%-0.01%-0.03%0.03%